166 related articles for article (PubMed ID: 28205004)
1. Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.
Välitalo P; Kokki M; Ranta VP; Olkkola KT; Hooker AC; Kokki H
Pharm Res; 2017 May; 34(5):1125-1133. PubMed ID: 28205004
[TBL] [Abstract][Full Text] [Related]
2. Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine.
Kokki M; Heikkinen M; Välitalo P; Hautajärvi H; Hokkanen J; Pitkänen H; Sankilampi U; Ranta VP; Kokki H
Br J Clin Pharmacol; 2017 Apr; 83(4):791-800. PubMed ID: 27780305
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of oxycodone: Premature neonates to adults.
Morse JD; Sundermann M; Hannam JA; Kokki H; Kokki M; Anderson BJ
Paediatr Anaesth; 2021 Dec; 31(12):1332-1339. PubMed ID: 34469607
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of oxycodone in children 6 months to 7 years old.
El-Tahtawy A; Kokki H; Reidenberg BE
J Clin Pharmacol; 2006 Apr; 46(4):433-42. PubMed ID: 16554451
[TBL] [Abstract][Full Text] [Related]
5. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
[TBL] [Abstract][Full Text] [Related]
6. Marked variation in oxycodone pharmacokinetics in infants.
Pokela ML; Anttila E; Seppälä T; Olkkola KT
Paediatr Anaesth; 2005 Jul; 15(7):560-5. PubMed ID: 15960639
[TBL] [Abstract][Full Text] [Related]
7. Oxycodone target concentration dosing for acute pain in children.
Morse JD; Hannam JA; Anderson BJ; Kokki H; Kokki M
Paediatr Anaesth; 2021 Dec; 31(12):1325-1331. PubMed ID: 34469616
[TBL] [Abstract][Full Text] [Related]
8. Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants.
Borsuk A; Wołoszczuk-Gębicka B; Bartkowska-Śniatkowska A; Rosada-Kurasińska J; Bienert A; Wiczling P
J Clin Pharmacol; 2017 Sep; 57(9):1194-1206. PubMed ID: 28510304
[TBL] [Abstract][Full Text] [Related]
9. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.
Allegaert K; Anderson BJ; Naulaers G; de Hoon J; Verbesselt R; Debeer A; Devlieger H; Tibboel D
Eur J Clin Pharmacol; 2004 May; 60(3):191-7. PubMed ID: 15071761
[TBL] [Abstract][Full Text] [Related]
10. Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?
Charles B; Hardy J; Anderson H; Tapuni A; George R; Norris R
Support Care Cancer; 2014 Feb; 22(2):325-30. PubMed ID: 24077699
[TBL] [Abstract][Full Text] [Related]
11. Prediction of morphine dose in humans.
Holford NH; Ma SC; Anderson BJ
Paediatr Anaesth; 2012 Mar; 22(3):209-22. PubMed ID: 22212108
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?
Mahmood I
Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Dosing Simulations of Intravenous Oxycodone for Perioperative Pain Relief in Adult Surgical Patients with Obesity.
Chaw SH; Lo YL; Yeap LL; Haron DEBM; Shariffuddin II
Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):11-21. PubMed ID: 36207565
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
Kokki H; Rasanen I; Reinikainen M; Suhonen P; Vanamo K; Ojanperä I
Clin Pharmacokinet; 2004; 43(9):613-22. PubMed ID: 15217304
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and analgesic potency of oxycodone.
Choi BM; Lee YH; An SM; Lee SH; Lee EK; Noh GJ
Br J Clin Pharmacol; 2017 Feb; 83(2):314-325. PubMed ID: 27558774
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
17. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
Mandema JW; Kaiko RF; Oshlack B; Reder RF; Stanski DR
Br J Clin Pharmacol; 1996 Dec; 42(6):747-56. PubMed ID: 8971431
[TBL] [Abstract][Full Text] [Related]
18. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis.
Anderson BJ; van Lingen RA; Hansen TG; Lin YC; Holford NH
Anesthesiology; 2002 Jun; 96(6):1336-45. PubMed ID: 12170045
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.
Ziesenitz VC; Vaughns JD; Koch G; Mikus G; van den Anker JN
Clin Pharmacokinet; 2018 Feb; 57(2):125-149. PubMed ID: 28688027
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oxycodone after intravenous and subcutaneous administration in Japanese patients with cancer pain.
Kokubun H; Yoshimoto T; Hojo M; Fukumura K; Matoba M
J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):338-50. PubMed ID: 25359452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
